Ming-Qian Zhou

Ming-Qian Zhou

Auto-generated profile, based on publicly available information

Ming-Qian Zhou

Division of Immunotherapy, The Hiram C. Polk, Jr. Department of Surgery, Immuno-Oncology Program, James Graham Brown Cancer Center, University of Louisville School of Medicine , Louisville, KY

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
YWYi-Qi Wang
Yi-Qi Wang
JMJin-Bo Mao
Jin-Bo Mao
MZMing-Qian Zhou
Ming-Qian Zhou
YJYa-Wei Jin
Ya-Wei Jin
CLCheng-Hua Lou
Cheng-Hua Lou
CWCheng-Ping Wen
Cheng-Ping Wen

1 September 2021 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
MZMingqian Zhou
Mingqian Zhou
PDPaul Dascani
Paul Dascani
CDChuanlin Ding
Chuanlin Ding
JKJustin T. Kos
Justin T. Kos
DTDavid Tieri
David Tieri
JYJun Yan
Jun Yan
Our previous work has revealed the ability of CD11b to regulate BCR signaling and control autoimmune disease in mice. However, how CD11b regulates the immune response under normal conditions remains unknown. Through the use of a CD11b knockout model on a nonautoimmune background, we demonstrated that CD11b-deficient mice have an elevated Ag-specific humoral response on immunization. Deletion of CD11b resulted in elevated low-affinity and high-affinity IgG Ab and increases in Ag-specific germinal center B cells and plasma cells (PCs). Examination of BCR signaling in CD11b-deficient mice revealed defects in association of negative regulators pLyn and CD22 with the BCR, but increases in colocalizations between positive regulator pSyk and BCR after stimulation. Using a CD11b-reporter mouse model, we identified multiple novel CD11b-expressing B cell subsets that are dynamically altered during immunization. Subsequent experiments using a cell-specific CD11b deletion model revealed this effect to be B cell intrinsic and not altered by myeloid cell CD11b expression. Importantly, CD11b expression on PCs also impacts on BCR repertoire selection and diversity in autoimmunity. These studies describe a novel role for CD11b in regulation of the healthy humoral response and autoimmunity, and reveal previously unknown populations of CD11b-expressing B cell subsets, suggesting a complex function for CD11b in B cells during development and activation.